Resources

Resource Centre

Reach the Clinic Faster: Integrated Biopharmaceutics & Drug Substance Strategies

Watch our on-demand, panel discussion webinar entitled 'Reach the Clinic Faster: Integrated Biopharmaceutics & Drug Substance Strategies'.

Strategies for Achieving Regulatory Milestones Faster

Watch our on-demand webinar featuring a customer case study from Ensysce Biosciences' CEO Lynn Kirkpatrick on choosing an integrated service provider to accelerate drug development.

Quotient Sciences and Charles River Collaboration Webinar

Watch Quotient Sciences & Charles River webinar on-demand entitled, 'Integrated Strategies for Accelerating from Discovery to IND and Beyond: Charles River & Quotient Sciences Collaboration'.

Bioanalytical Strategies for Insulin Analogues & Other Large Peptides Using LC-MS

Learn how our physiochemical-based approach enables us to accelerate the development of bioanalytical assays for insulin analogues from Michael Blackburn, Head of Bioanalytical Method Development and Labs.

Navigating the Small Molecule CMC Pathway

Learn about drug substance and formulation considerations for improving downstream clinical outcomes. Access on demand.

Streamlining the Delivery of 14C Human ADME Data: An ADME Q&A Roundtable

Experts from Quotient Sciences and The Netherlands Organization for Applied Scientific Research (TNO) discuss streamlining human ADME studies.

Non-Clinical vs Clinical: Risks & Considerations When Developing Modified Release Dosage Forms

Dr. Vanessa Zann, Senior Drug Development Consultant, discusses specialized technologies used to optimize modified-release formulations.

Getting it Right Early: The Importance of Biopharmaceutics in Early Drug Development

Chris Roe, Quotient Sciences' Principal Research Fellow, discusses strategies for overcoming biopharmaceutic challenges for small molecules in today’s drug development.

The Role of Biopharmaceutics in Early Drug Development

This webinar discusses effective strategies being used by biotech and pharmaceutical companies to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline; and explores alternative approaches for accelerating your early development plan.

Tufts CSDD Study Assessing the Financial Benefits of Translational Pharmaceutics®: A Platform for Accelerating Product Development

This webinar summarizes the key findings of the recent Tufts CSDD research into Translational Pharmaceutics, the innovative approach to drug development. Access our on-demand webinar now.